Rebecca Robbins & Sheryl Gay Stolberg

Jul 23, 2023

Drug Co. Profited by Slow-Walking HIV Fix

In 2004, Gilead Sciences decided to stop pursuing a new H.I.V. drug. The public explanation was that it wasn’t sufficiently